Eagle Asset Management Inc Invitae Corp Transaction History

Eagle Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $8.5 Million - $16.6 Million	-578,179 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$24.31 - $33.6 $9,821 - $13,574	-404 Reduced 0.07%	578,179 $16.4 Million
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $374,600 - $580,063	14,358 Added 2.54%	578,583 $19.5 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $1.47 Million - $2.54 Million	44,552 Added 8.57%	564,225 $22.1 Million
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $1.73 Million - $2.54 Million	-44,203 Reduced 7.84%	519,673 $21.7 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $16 Million - $25.2 Million	563,876 New	563,876 $25 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.